On 2025-05-06, Arcutis Biotherapeutics, Inc. (ARQT) announced earnings per share of $-0.20 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.21.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.19 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2025-05-06 | 2025-03-31 | $-0.21 | $-0.20 |
2025-02-25 | 2024-12-31 | $-0.27 | $-0.09 |
2024-11-06 | 2024-09-30 | $-0.42 | $-0.33 |
2024-08-14 | 2024-06-30 | $-0.48 | $-0.42 |
2024-05-14 | 2024-03-31 | $-0.60 | $-0.32 |
2024-02-27 | 2023-12-31 | $-0.65 | $-0.72 |
2023-11-03 | 2023-09-30 | $-0.90 | $-0.73 |
2023-08-08 | 2023-06-30 | $-1.22 | $-1.16 |
2023-05-09 | 2023-03-31 | $-1.30 | $-1.31 |
2023-02-28 | 2022-12-31 | $-1.37 | $-1.18 |
2022-11-08 | 2022-09-30 | $-1.54 | $-1.89 |
2022-08-04 | 2022-06-30 | $-1.38 | $-1.31 |
2022-05-05 | 2022-03-31 | $-1.42 | $-1.27 |
2022-02-22 | 2021-12-31 | $-1.41 | $-1.42 |
2021-11-04 | 2021-09-30 | $-1.09 | $-1.14 |
2021-08-05 | 2021-06-30 | $-0.91 | $-0.84 |
2021-05-04 | 2021-03-31 | -- | $-0.76 |
2021-02-16 | 2020-12-31 | $-0.89 | $-0.79 |
2020-11-05 | 2020-09-30 | $-0.95 | $-1.01 |
2020-08-11 | 2020-06-30 | -- | $-0.94 |
2020-05-12 | 2020-03-31 | -- | $-1.15 |
2020-03-19 | 2019-12-31 | -- | $-6.13 |